Medical device company SurgiVision postpones IPO
7/30/2010
SurgiVision, which has developed an MRI-guided device for minimally invasive brain procedures, postponed its IPO on Friday because of poor market conditions. The Memphis, TN-based company was founded in 1998 and booked $2.6 mil in sales last year. Canaccord Genuity and Rodman & Renshaw were set to be the lead underwriters on the deal.
View IPO Profile:
SRGV
|
DLC Realty Trust sets terms for $500 million IPO
7/30/2010
DLC Realty Trust, a self-managed REIT with a portfolio of 86 value-focused shopping centers, announced terms for its IPO on Friday. The Tarrytown, NY-based company plans to raise $500 million by offering 31.25 million shares at a price range of $15-$17. At the mid-point of the proposed range, DLC Realty Trust will command a market value of $849 million. DLC Realty Trust, which was founded in 1991 and booked $163 million in sales last year, plans to list on the NYSE under the symbol DLC. BofA Merrill Lynch and Barclays Capital are the lead underwriters on the deal, which is expected to price during the week of August 9.
View IPO Profile:
DLC
|
SiGe Semiconductor files for a $144 million IPO
7/29/2010
SiGe Semiconductor, which is a leading provider of radio frequency semiconductor front end solutions used in wireless products, filed on Thursday with the SEC to raise up to $144 million in an initial public offering. The Andover, MA-based company, which was founded in 1996 and booked $83 million in sales last year, plans to list on the NASDAQ under the symbol SIGE. Barclays Capital, Deutsche Bank Securities and Jefferies & Co. are the lead underwriters on the deal. No pricing terms were disclosed.
View IPO Profile:
SIGE
|
India-based online travel company MakeMyTrip sets IPO terms
7/29/2010
MakeMyTrip Limited, the largest online travel company in India, announced terms for its IPO on Thursday. The Haryana-based company plans to raise $65 million by offering 5 million shares at a price range of $12-$14. At the mid-point of the proposed range, MakeMyTrip will command a market value of $444 million. MakeMyTrip, which was founded in 2000 and booked $84 million in sales for the 12 months ended March 31, plans to list on the NASDAQ under the symbol MMYT. Morgan Stanley, Oppenheimer & Co. and Pacific Crest are the lead underwriters on the deal, for which timing was not disclosed.
View IPO Profile:
MMYT
|
Molycorp prices IPO at $14.00, below the original range
7/29/2010
Molycorp, the only rare earth oxide (REO) producer in the Western Hemisphere, raised $394 million by offering 28,125,000 shares at $14.00, below the range of $15.00 to $17.00. Molycorp plans to list on the NYSE under the symbol MCP. Morgan Stanley and JPMorgan acted as lead managers on the deal.
View IPO Profile:
MCP
|
|
|
